International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 12

Review Papers | Radiology and Medical Imaging Sciences | Volume 12 Issue 4, April 2023 | Pages: 1136 - 1139 | Bulgaria


Hereditary Hemorrhagic Telangiectasia: Recognizing, Screening and Treating from a Neurological Point of View

Vladev G., Sirakova K.

Abstract: The Osler-Weber-Rendu condition, also known as hereditary hemorrhagic telangiectasia (HHT), is a rare genetic disorder affecting various areas of the human body. Two prevalent genotypes involve mutations in the endoglin gene (HHT-type 1) and the ALK-1 gene (HHT-type 2). These genetic alterations result in abnormal blood vessels, such as arteriovenous malformations (AVMs) in the liver, lungs, and brain (1) . Patients frequently experience continuous nosebleeds and gastrointestinal bleeding, leading to iron deficiency anemia. Liver and lung AVMs can lead to various clinical presentations, including portal hypertension, encephalopathy, and high-output cardiac failure in the liver, and shortness of breath, respiratory distress, and stroke events in the lungs (2). The prevalence of brain AVMs in HHT patients ranges from 10-20% (3, 4) , more frequently linked to the HHT-type 1 genotype. Symptoms include headaches, seizures, and intracranial hemorrhage (ICH). Identifying affected patients can aid in family-wide screening, resulting in improved diagnostics and patient outcomes. Neurointerventionalists play a crucial role in diagnosing and treating cerebral vascular malformations, with most of the brain AVMs being categorized as Spetzler-Martin grades I-II (5) . A comprehensive physical examination, can lead to the observation of several HHT symptoms in such patients, leading to an Osler-Weber-Rendu disease clinical diagnosis. All patients should undergo diagnostic MRI or CT scans, which would verify the presence of a brain AVMs, and subsequently be discussed for endovascular therapy.

Keywords: Hereditary hemorrhagic telangiectasia, embolization

How to Cite?: Vladev G., Sirakova K., "Hereditary Hemorrhagic Telangiectasia: Recognizing, Screening and Treating from a Neurological Point of View", Volume 12 Issue 4, April 2023, International Journal of Science and Research (IJSR), Pages: 1136-1139, https://www.ijsr.net/getabstract.php?paperid=SR23418145420, DOI: https://dx.doi.org/10.21275/SR23418145420

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.